QT
ALDX icon

Quantbot Technologies’s Aldeyra Therapeutics ALDX Stock Holding History

Quantbot Technologies’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,795
Closed -$6.41K – 1903
2026
Q1 		$6.41K Buy
+3,795
New +$16.6K ﹤0.01% 1566
2022
Q3 		– Sell
-4,668
Closed -$18K – 1551
2022
Q2 		$18K Buy
+4,668
New +$16.1K ﹤0.01% 1458

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Quantbot Technologies's ALDX Position: Q2 2026 in Review

Quantbot Technologies sold out of Aldeyra Therapeutics (ALDX) in Q2 2026, closing a stake of 3,795 shares — an estimated $6.41K sold.

Quantbot Technologies first reported a position in ALDX in Q2 2022 and held it in 2 quarters. The position peaked at $18K in Q2 2022. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Quantbot Technologies reported no remaining Aldeyra Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 3,795 Aldeyra Therapeutics shares in Q2 2026, an estimated $6.41K.
  • Quantbot Technologies first reported a position in Aldeyra Therapeutics in Q2 2022 and held it in 2 quarters.
  • Quantbot Technologies's Aldeyra Therapeutics position peaked at $18K in Q2 2022.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.